泰宗 News Releases

Tai Tsung Invited to Participate in Corporate Briefing Hosted by Yuanta Securities to Present Business Overview

Tai Tsung has been invited to attend the corporate briefing hosted by Yuanta Securities to present a… · 2026-06-19

【Tsai Tsung】 (Supplementary Announcement) Notice of Board Meeting to Submit the Financial Report for the First Quarter of 115

Tsai Tsung Company issued a supplementary announcement notifying that the financial report for the f… · 2026-06-08

[TCM] Resolution on Lifting Non-Compete Restrictions for Directors at the 2026 Annual General Shareholders' Meeting

TCM Biotech announced that at its 2026 Annual General Shareholders' Meeting held on June 5, it passe… · 2026-06-05

[TaiGen] Announcement of Election Results for the Board of Directors at the 2026 Annual General Shareholders' Meeting

TaiGen Biotechnology held its Annual General Shareholders' Meeting on June 5, 2026, to conduct a ful… · 2026-06-05

[TaiGen] Announcement of the 4th Audit Committee Members and Convener

TaiGen Biotechnology announced that the members and convener of its 4th Audit Committee—Kuo Cheng-hu… · 2026-06-05

[TaiGen] Announcement on Board Selection of Chairman (Re-election)

TaiGen Biotechnology announced that the board of directors selected Xu Huanqing to continue as Chair… · 2026-06-05

[TaiGen] Announcement regarding the expiration of the term of the 5th Compensation and Nomination Committee members

TaiGen Biotechnology announced that, due to the expiration of the Board of Directors' term, the term… · 2026-06-05

[Apex] Announcement regarding the expiration of the term of the 1st Sustainability Committee

Apex Medical Corp announced that the term of its 1st Sustainability Committee has expired in conjunc… · 2026-06-05

[Tai Zong] Announcement of Important Resolutions of the 2026 Annual General Meeting of Shareholders

Tai Zong held its Annual General Meeting on June 5, 2026, approving the earnings distribution for th… · 2026-06-05

Taisun Biotech Corrects Errors in Its Q1 2026 Consolidated Financial Report

On May 20, 2026, Taisun Biotechnology Co., Ltd. announced a correction to its Q1 2026 consolidated f… · 2026-05-20

[Tai Tsung] Announcement of the Company's Subscription to Private Placement Ordinary Shares of Xiangyi Pharmaceutical Co., Ltd.

Tai Tsung announced its plan to strategically invest in Xiangyi Pharmaceutical by subscribing to 20 … · 2026-05-07

【TaiGen】The Company's Board of Directors Resolves to Waive Non-Compete Restrictions for Managers

TaiGen announced that its Board of Directors approved waiving non-compete restrictions for Chairman … · 2026-05-07

【TaiGen】The Company's Board of Directors Resolves to Approve the 2026 Q1 Consolidated Financial Report

TaiGen Biotechnology announced that its Board of Directors approved the 2026 Q1 consolidated financi… · 2026-05-07

【TaiGen】The Company's Board of Directors Resolves to Waive Non-Compete Restrictions for Managers

TaiGen announced that its Board of Directors approved waiving non-compete restrictions for Chairman … · 2026-05-07

【TaiGen】The Company's Board of Directors Resolves to Approve the 2026 Q1 Consolidated Financial Report

TaiGen Biotechnology announced that its Board of Directors approved the 2026 Q1 consolidated financi… · 2026-05-07

[Tai Tsung] Announcement of the Company's Subscription to Private Placement Ordinary Shares of Xiangyi Pharmaceutical Co., Ltd.

Tai Tsung announced its plan to strategically invest in Xiangyi Pharmaceutical by subscribing to 20 … · 2026-05-07

Tai Tsung Reports May 2026 Revenue of NT$57.163 Million (YoY -17.2%)

Tai Tsung (stock code: 4169), a biotechnology and healthcare company, announced its revenue for May … · 2026-05-01

[Biotegy] Results of stabilization operations for the first five trading days following the company's listing

Biotegy announced that during its first five days of listing, the underwriter purchased 0 shares for… · 2026-04-16

[Biotegy] Results of stabilization operations for the first five trading days following the company's listing

Biotegy announced that during its first five days of listing, the underwriter purchased 0 shares for… · 2026-04-16

Taizong Biotech: Announcement Regarding Termination of OTC Trading and Listing on Taiwan Stock Exchange

Taizong Biotech announced that its stock will terminate OTC trading and be listed on the Taiwan Stoc… · 2026-04-07

Taizong Biotech: Announcement Regarding Termination of OTC Trading and Listing on Taiwan Stock Exchange

Taizong Biotech announced that its stock will terminate OTC trading and be listed on the Taiwan Stoc… · 2026-04-07

Taizong Biotech: Announcement Regarding Termination of OTC Trading and Listing on Taiwan Stock Exchange

Taizong Biotech announced that its stock will terminate OTC trading and be listed on the Taiwan Stoc… · 2026-04-07

【Taixong】April 2026 Revenue 59.14 Million NTD (Year-on-Year +15.4%)

Taixong (4169), a biotechnology and medical company, reported April 2026 revenue of 59.14 million NT… · 2026-04-01

【Taixong】April 2026 Revenue 59.14 Million NTD (Year-on-Year +15.4%)

Taixong (4169), a biotechnology and medical company, reported April 2026 revenue of 59.14 million NT… · 2026-04-01

Tai-Tsung Corp. March 2026 Revenue NT$62 million (YoY +9.1%)

Tai-Tsung's monthly revenue for March 2026 was NT$62 million, an increase of 9.1% year-over-year. Th… · 2026-03-01

Tai-Tsung Corp. March 2026 Revenue NT$62 million (YoY +9.1%)

Tai-Tsung's monthly revenue for March 2026 was NT$62 million, an increase of 9.1% year-over-year. Th… · 2026-03-01